You are here
- Home
Research
Our scientists share a common goal: to get life-changing medicines to patients as quickly, safely and efficiently as possible.
-
Research partnerships expand
Positioned for the future collapse
We have a robust and expanding pipeline that includes small molecules, biologics and vaccines, addressing areas that represent unmet medical need.
New opportunities collapse
We have over 1000 active collaborations with external partners across the globe and we continue to look for innovation & opportunity within and beyond our existing research areas.
-
Seeking solutions collapse
We devote our skills and resources to finding breakthrough therapies in areas where we believe we have particular scientific insight and expertise.
Powerful global reach collapse
AstraZeneca has more than 65,000 employees worldwide. About 12,000 are dedicated to R&D at 17 principal centres in eight countries.
Research and Development collapse
Not signed in
Page tools
Share price
- London
-
26.95 GBP - New York
-
44.82 USD - Stockholm
-
310.10 SEK
At 21-Nov-2009 09:15 GMT
Detailed share priceIntroduction to AstraZeneca
Our responsibility
We continue to communicate openly on a range of issues, including:
